STRS Ohio’s Exagen XGN Stock Holding History

STRS Ohio’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-900	Closed	-$14K	–	2267
2020 Q1	$14K	Hold	900	–	–	﹤0.01%	1925
2019 Q4	$22K	Buy	+900	New	+$16K	﹤0.01%	1966

Other funds holding XGN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

STRS Ohio's XGN Position: Q2 2020 in Review

STRS Ohio sold out of Exagen (XGN) in Q2 2020, closing a stake of 900 shares — an estimated $14K sold.

STRS Ohio first reported a position in XGN in Q4 2019 and held it in 2 quarters. The position peaked at $22K in Q4 2019. 34 funds tracked by Wall St. Rank hold XGN as of Q2 2020.

STRS Ohio reported no remaining Exagen position as of Q2 2020 after selling out during the quarter.
STRS Ohio sold 900 Exagen shares in Q2 2020, an estimated $14K.
STRS Ohio first reported a position in Exagen in Q4 2019 and held it in 2 quarters.
STRS Ohio's Exagen position peaked at $22K in Q4 2019.
34 funds tracked by Wall St. Rank held Exagen as of Q2 2020.

Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.